Global Premature Ejaculation Treatment Market 2017-2021

Publisher Name :
Date: 15-Nov-2017
No. of pages: 84
Price : Single User: US $ 3500  US $ 2500 Corporate User: US $ 5000  US $ 4000
Inquire Before Buying
Avail $1000 Discount on this report till 31st December, 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Premature ejaculation is one of the most common sexual dysfunctions occurring in men. Ejaculation happens sooner than desired, either shortly or before penetration, resulting in distress to either one or both partners involved in sexual intercourse. There is no exact cause that can be associated with the condition though mostly, premature ejaculation can be attributed to personal distress and anxiety. It can affect an individual's relationship with his partner. Premature ejaculation is the most common sexual disorder found in men aged between 18 to 59. Some of the effective treatment options available include psychological counseling, medications, sexual techniques that delay ejaculation, or a combination of these treatments.

The analysts forecast global premature ejaculation treatment market to grow at a CAGR of 8.71% during the period 2017-2021.

Covered in this report

This report covers the present scenario and the growth prospects of the global premature ejaculation treatment market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:


  • Americas

  • APAC

  • EMEA


This report, Global Premature Ejaculation Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


  • Absorption Pharmaceuticals

  • Bayer

  • Eli Lilly

  • Regent Pacific Group


Other prominent vendors


  • Dong-A Pharmaceutical

  • Emcure

  • Futura Medical

  • GlaxoSmithKline

  • NeuroHealing Pharmaceuticals

  • Pfizer


Market driver


  • High use of off-label drugs

  • For a full, detailed list, view our report


Market challenge


  • Alternative treatments

  • For a full, detailed list, view our report


Market trend


  • Growing online retail sales of drugs

  • For a full, detailed list, view our report


Key questions answered in this report


  • What will the market size be in 2021 and what will the growth rate be?

  • What are the key market trends?

  • What is driving this market?

  • What are the challenges to market growth?

  • Who are the key vendors in this market space?

Avail $1000 Discount on this report till 31st December, 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Global Premature Ejaculation Treatment Market 2017-2021

Table of Contents

PART 01: Executive Summary

PART 02: Scope of the Report

PART 03: Research Methodology

PART 04: Introduction
Market Outline

PART 05: Premature Ejaculation: Disease Overview

PART 06: Market Landscape
Market Overview
Five Forces Analysis

PART 07: Pipeline Landscape

PART 08: Market Segmentation by Route of Administration
Oral Route of Administration
Topical Route of Administration

PART 09: Market Segmentation by Drug Class
Ssris
Pde5 Inhibitors
Amide Anesthetics
Others

PART 10: Regional Landscape
Regional Comparison
Premature Ejaculation Treatment Market in Americas
Premature Ejaculation Treatment Market in EMEA
Premature Ejaculation Treatment Market in APAC
Key Leading Countries
Market Opportunity

PART 11: Decision Framework

PART 12: Drivers and Challenges
Market Drivers
Market Challenges

PART 13: Market Trends
Growing Online Retail Sales of Drugs
Increase in Awareness of Premature Ejaculation
New Treatment Methods

PART 14: Vendor Landscape
Competitive Scenario

PART 15: Key Vendor Analysis
Absorption Pharmaceuticals
Bayer
Eli Lilly
Regent Pacific Group
Other Prominent Vendors

PART 16: Appendix
List of Abbreviations

List of Exhibits

Exhibit 01: Global Premature Ejaculation Treatment Market: Overview
Exhibit 02: Facts About Premature Ejaculation
Exhibit 03: Severity Levels of Premature Ejaculation
Exhibit 04: Clinical Diagnosis of Premature Ejaculation
Exhibit 05: Premature Ejaculation Classification
Exhibit 06: Global Premature Ejaculation Treatment Market 2016-2021 ($ Millions)
Exhibit 07: Five Forces Analysis
Exhibit 08: Pipeline Molecules by Vendors
Exhibit 09: Key Clinical Trials
Exhibit 10: Global Premature Ejaculation Treatment Market by Route of Administration 2016
Exhibit 11: Global Premature Ejaculation Treatment Market by Ssris 2016-2021 ($ Millions)
Exhibit 12: Global Premature Ejaculation Treatment Market by Pde5 Inhibitors 2016-2021 ($ Millions)
Exhibit 13: Global Premature Ejaculation Treatment Market by Amide Anesthetics 2016-2021 ($ Millions)
Exhibit 14: Global Premature Ejaculation Treatment Market by Others 2016-2021 ($ Millions)
Exhibit 15: Global Premature Ejaculation Treatment Market by Region 2016-2021 (% Share)
Exhibit 16: Regional Comparison
Exhibit 17: Premature Ejaculation Treatment Market in Americas 2016-2021 ($ Millions)
Exhibit 18: Premature Ejaculation Treatment Market in Americas - Year Over Year Growth
Exhibit 19: Premature Ejaculation Treatment Market in EMEA 2016-2021 ($ Millions)
Exhibit 20: Premature Ejaculation Treatment Market in EMEA - Year Over Year Growth
Exhibit 21: Premature Ejaculation Treatment Market in APAC 2016-2021 ($ Millions)
Exhibit 22: Premature Ejaculation Treatment Market in APAC - Year Over Year Growth
Exhibit 23: Key Leading Countries
Exhibit 24: Pharmacologic Efficacy of Some Ssris
Exhibit 25: Premature Ejaculation Treatment Drugs and Their Subsequent Side Effects
Exhibit 26: Factors Challenging the Treatment of Premature Ejaculation
Exhibit 27: Absorption Pharmaceuticals: Key Highlights
Exhibit 28: Absorption Pharmaceuticals: Strength Assessment
Exhibit 29: Absorption Pharmaceuticals: Strategy Assessment
Exhibit 30: Absorption Pharmaceuticals: Opportunity Assessment
Exhibit 31: Bayer: Key Highlights
Exhibit 32: Bayer: Strength Assessment
Exhibit 33: Bayer: Strategy Assessment
Exhibit 34: Bayer: Opportunity Assessment
Exhibit 35: Eli Lilly: Key Highlights
Exhibit 36: Eli Lilly: Strength Assessment
Exhibit 37: Eli Lilly: Strategy Assessment
Exhibit 38: Eli Lilly: Opportunity Assessment
Exhibit 39: Regent Pacific Group: Key Highlights
Exhibit 40: Regent Pacific Group: Strength Assessment
Exhibit 41: Regent Pacific Group: Strategy Assessment
Exhibit 42: Regent Pacific Group: Opportunity Assessment

  • Global and Regional Testosterone Replacement Therapy Market Research Report 2017
    Published: 08-Dec-2017        Price: US 3500 Onwards        Pages: 126
    Summary Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development. Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East......
  • Global Testosterone Replacement Therapy Market Research Report 2017
    Published: 08-Dec-2017        Price: US 2900 Onwards        Pages: 111
    In this report, the global Testosterone Replacement Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Testosterone Replacement Therapy in these regions, from 2012 to 2022 (forecast), covering - North America - ......
  • North America Testosterone Replacement Therapy Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 24-Nov-2017        Price: US 4480 Onwards        Pages: 117
    Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.Scope of the Report:This report focuses on the Testosterone Replacement Therapy in North America market, especially in United States, Canada and Mexico. This report categor......
  • Benign Prostatic Hyperplasia - Pipeline Review, H2 2017
    Published: 14-Nov-2017        Price: US 2000 Onwards        Pages: 113
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Benign Prostatic Hyperplasia - Pipeline Review, H2 2017, provides an overview of the Benign Prostatic Hyperplasia (Male Health) pipeline landscape. Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate, a small gland that encircles the urethra in males and produces a fluid that makes up part of semen. Symptoms include decreased strength of the urine stream, dribbling aft......
  • Secondary (Hypogonadotropic) Hypogonadism - Pipeline Review, H2 2017
    Published: 14-Nov-2017        Price: US 2000 Onwards        Pages: 58
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary (Hypogonadotropic) Hypogonadism - Pipeline Review, H2 2017, provides an overview of the Secondary (Hypogonadotropic) Hypogonadism (Male Health) pipeline landscape. Hypogonadotropic hypogonadism (HH) is a form of hypogonadism that is due to a problem with the pituitary gland or hypothalamus. HH is caused by a lack of hormones that normally stimulate the ovaries or testes like gonadotropin-......
  • Erectile Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Erectile Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Erectile Dysfunction. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Erectile Dysfunction wh......
  • Male Hypogonadism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2250 Onwards        Pages: 120
    DelveInsight's, Male Hypogonadism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Male Hypogonadism. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Male Hypogonadism which can t......
  • Global Testosterone Replacement Therapy Market Professional Survey Report 2017
    Published: 01-Nov-2017        Price: US 3500 Onwards        Pages: 117
    This report studies Testosterone Replacement Therapy in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - AbbVie - Endo International - Eli lilly - Pfizer......
  • Erectile Dysfunction - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1500 Onwards        Pages: 70
    DelveInsight's, " Erectile Dysfunction -Pipeline Insights, 2017", report provides comprehensive insights about pipeline drugs across this Erectile Dysfunction. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Erectile Dysfunction. This report provides information on the therapeutic development for Erectile Dysfunction, dealing with all the pipeline drugs and comparative analysis at various stages covering all clinica......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs